CRBP

Corbus Pharmaceuticals Holdings Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 4/10
  • Value↑ 5/10
Corbus Pharmaceuticals Holdings sales and earnings growth
CRBP Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -36.67%
  • FCF Y/Y↓ -46.58%
Corbus Pharmaceuticals Holdings gross and profit margin trends
CRBP Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -70.30%
Corbus Pharmaceuticals Holdings net debt vs free cash flow
CRBP Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Corbus Pharmaceuticals Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks